Thyroid Receptor Antibody and the Development of Graves’ Orbitopathy: Clinical Experience of using Radioiodine Ablation in the Management of Graves’ Orbitopathy in post-iodine ablation hypothyroid patient

Graves’ disease (GD) is the commonest cause of hyperthyroidism, accounted for 70-80% in iodine sufficient countries and up to 50% in iodine deficient countries. Combination of genetic predisposition and environmental factors influences the development of GD. Graves’ orbitopathy (GO) represents the m...

Descripción completa

Detalles Bibliográficos
Autores principales: Christina, Edelyn, Budiawan, Hendra, Indrawati, Hapsari, Affandi Soeriadi, Erwin, Nugrahadi, Trias, Kartamihardja, A Hussein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261695/
https://www.ncbi.nlm.nih.gov/pubmed/37324233
http://dx.doi.org/10.22038/AOJNMB.2023.68546.1478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261695/
https://www.ncbi.nlm.nih.gov/pubmed/37324233
http://dx.doi.org/10.22038/AOJNMB.2023.68546.1478

Ejemplares similares